A randomized, open label study to compare the effect of combination treatment with PEGASYS + adefovir dipivoxil versus PEGASYS monotherapy on HBV-DNA and ALT levels in patients with HBeAg-negative, chronic hepatitis B.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Adefovir dipivoxil; Peginterferon alfa-2a
- Indications Hepatitis B
- Focus Registrational; Therapeutic Use
- Acronyms ADVANCE
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 19 Sep 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 19 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.